Literature DB >> 17442429

Interleukin-8 as an independent predictor of long-term clinical outcome in patients with coronary artery disease.

Teruo Inoue1, Hiroshi Komoda, Masako Nonaka, Miho Kameda, Toshihiko Uchida, Koichi Node.   

Abstract

BACKGROUND: Accumulating evidence suggests that inflammation plays an essential role in the pathogenesis of atherosclerosis and that circulating inflammatory markers predict future cardiovascular events. However, previous studies evaluated the predictive value of only a single cytokine at a time. AIMS: This study was designed to simultaneously measure plasma levels of multiple cytokines in patients with coronary artery disease and to evaluate their ability to predict long-term prognosis.
METHODS: The study enrolled 158 consecutive patients with angiographically identified stable coronary artery disease. Using the Luminex micro-beads array system, we simultaneously measured plasma levels of the following 10 cytokines: interleukin (IL)-1beta, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, tumor necrosis factor (TNF)-alpha, granulocyte-macrophage colony stimulating factor (GM-CSF) and gamma-interferon (IFN-gamma).
RESULTS: None of the 10 cytokine levels as well as high-sensitive C reactive protein (hs-CRP) was correlated with the severity of coronary artery disease. During a 7-year follow-up period, cardiovascular events occurred in 56 patients (35%). Multi-vessel disease, diabetes, and high levels of all of the 10 measured cytokines and hs-CRP were significant predictors of cardiovascular events in univariate analysis. However, multivariate analysis using multi-vessel disease, diabetes and the levels of all of 10 cytokines and hs-CRP showed that the only independent predictor was IL-8 (RR, 2.98; 95%CI, 1.64-7.24; P=0.0001).
CONCLUSION: IL-8 was the only cytokine that predicted cardiovascular events independent of the other 9 cytokines and hs-CRP. Since IL-8 is a neutrophil chemokine, these results suggest that neutrophil activation may be related to the occurrence of cardiovascular events.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17442429     DOI: 10.1016/j.ijcard.2007.02.012

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  32 in total

1.  The late-phase inflammatory response after drug-eluting stent implantation.

Authors:  Isao Taguchi; Shuichi Yoneda; Shichiro Abe; Shigeru Toyoda; Takahisa Nasuno; Setsu Nishino; Michiya Kageyama; Michiaki Tokura; Mikie Ogawa; Koichi Node; Teruo Inoue
Journal:  Heart Vessels       Date:  2013-05-07       Impact factor: 2.037

Review 2.  An integrated approach to coronary heart disease diagnosis and clinical management.

Authors:  Teresa Infante; Ernesto Forte; Concetta Schiano; Carlo Cavaliere; Carlo Tedeschi; Andrea Soricelli; Marco Salvatore; Claudio Napoli
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

3.  Acute effects of statin on reduction of angiopoietin-like 2 and glyceraldehyde-derived advanced glycation end-products levels in patients with acute myocardial infarction: a message from SAMIT (Statin for Acute Myocardial Infarction Trial).

Authors:  Mitsuhiro Shimomura; Jun-Ichi Oyama; Masayoshi Takeuchi; Yoshisato Shibata; Yusuke Yamamoto; Tomohiro Kawasaki; Hiroshi Komoda; Kazuhisa Kodama; Masashi Sakuma; Shigeru Toyoda; Yohei Inoue; Daigo Mine; Masahiro Natsuaki; Aiko Komatsu; Yutaka Hikichi; Sho-Ichi Yamagishi; Teruo Inoue; Koichi Node
Journal:  Heart Vessels       Date:  2015-12-23       Impact factor: 2.037

Review 4.  Consolidated and emerging inflammatory markers in coronary artery disease.

Authors:  Valter Lubrano; Silvana Balzan
Journal:  World J Exp Med       Date:  2015-02-20

5.  7-ketocholesterol-induced inflammation: involvement of multiple kinase signaling pathways via NFκB but independently of reactive oxygen species formation.

Authors:  Ignacio M Larrayoz; Jiahn-Dar Huang; Jung Wha Lee; Iranzu Pascual; Ignacio R Rodríguez
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06-16       Impact factor: 4.799

6.  Inflammatory "adiposopathy" in major amputation patients.

Authors:  Christine R Mauro; Binh T Nguyen; Peng Yu; Ming Tao; Ian Gao; Michael A Seidman; Louis L Nguyen; C Keith Ozaki
Journal:  Ann Vasc Surg       Date:  2013-04       Impact factor: 1.466

7.  Interleukin 8 and susceptibility to coronary artery disease: a population genetics perspective.

Authors:  Konstantina Vogiatzi; Stavros Apostolakis; Vassilios Voudris; Sophia Thomopoulou; Georgios E Kochiadakis; Demetrios A Spandidos
Journal:  J Clin Immunol       Date:  2008-04-02       Impact factor: 8.317

8.  Roles of ERK and NF-kappaB in Interleukin-8 Expression in Response to Heat Shock Protein 22 in Vascular Smooth Muscle Cells.

Authors:  Seung-Hun Kang; Ji-Hyuk Lee; Kyung-Ha Choi; Byung-Yong Rhim; Koanhoi Kim
Journal:  Korean J Physiol Pharmacol       Date:  2008-08-31       Impact factor: 2.016

9.  Interleukin-18 predicts atherosclerosis progression in SIV-infected and uninfected rhesus monkeys (Macaca mulatta) on a high-fat/high-cholesterol diet.

Authors:  Jennifer H Yearley; Dongling Xia; Christine B Pearson; Angela Carville; Richard P Shannon; Keith G Mansfield
Journal:  Lab Invest       Date:  2009-04-20       Impact factor: 5.662

Review 10.  Experimental models investigating the inflammatory basis of atherosclerosis.

Authors:  Ahmed Soliman; Patrick Kee
Journal:  Curr Atheroscler Rep       Date:  2008-06       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.